Soleno Therapeutics has recently filed with the U.S. Securities and Exchange Commission, officially announcing the withdrawal of its marketing authorization application for the drug Viokas in Europe.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This decision marks the temporary suspension of the commercialization process of this drug in the European market.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like

A recorder hidden in toilet paper exposes OpenAI's long-standing safety issues
MEnews•2026/11/04 02:57

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs
AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.
智通财经•2026/11/04 02:51
BNB fell below $690
金色财经•2026/11/04 02:37

Crypto prices
MoreBitcoin
BTC
$76,238.77
-0.72%
Ethereum
ETH
$2,242.97
-0.22%
Tether USDt
USDT
$0.9986
+0.03%
BNB
BNB
$685.9
-1.16%
XRP
XRP
$1.26
+0.49%
USDC
USDC
$0.9998
+0.02%
Solana
SOL
$90.7
-1.40%
TRON
TRX
$0.3213
+0.10%
Hyperliquid
HYPE
$82.32
-0.50%
Zcash
ZEC
$1,174.52
+3.17%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now